The frequency of EGFR And KRAS mutations in the Turkish population with non-small cell lung cancer and their response to erlotinib therapy
By: A Demiray, A Yaren, N Karagenç, F Bir, AG Demiray, ER Karagür, O Tokgün, L Elmas and H Akça
Authors
A Demiray
Medical Biology Department, Pamukkale University, Denizli, Turkey
A Yaren
Medical Oncology Department, Pamukkale University, Denizli, Turkey
N Karagenç
Medical Biology Department, Pamukkale University, Denizli, Turkey
F Bir
Medical Pathology Department, Pamukkale University School of Medicine, Denizli, Turkey
AG Demiray
Medical Oncology Department, Pamukkale University, Denizli, Turkey
ER Karagür
Medical Biology Department, Pamukkale University, Denizli, Turkey
O Tokgün
Medical Biology Department, Pamukkale University, Denizli, Turkey
L Elmas
Medical Biology Department, Pamukkale University, Denizli, Turkey
DOI: https://doi.org/10.2478/bjmg-2018-0022 | Journal eISSN: 2199-5761 (formerly 1311-0160) | Journal ISSN: 1311-0160
Language: English
Page range: 21 - 26
Published on: Dec 31, 2018
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2018 A Demiray, A Yaren, N Karagenç, F Bir, AG Demiray, ER Karagür, O Tokgün, L Elmas, H Akça, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.